Control of Blood Pressure and Risk Attenuation: Post Trial Follow-Up of Randomized Groups.
Evidence on long term effectiveness of public health strategies for lowering blood pressure (BP) is scarce. In the Control of Blood Pressure and Risk Attenuation (COBRA) Trial, a 2 x 2 factorial, cluster randomized controlled trial, the combined home health education (HHE) and trained general practi...
| Main Authors: | , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2015-01-01
|
| Series: | PLoS ONE |
| Online Access: | http://europepmc.org/articles/PMC4634976?pdf=render |
| _version_ | 1828375661139460096 |
|---|---|
| author | Tazeen H Jafar Imtiaz Jehan Feng Liang Sylvaine Barbier Muhammad Islam Rasool Bux Aamir Hameed Khan Nivedita Nadkarni Neil Poulter Nish Chaturvedi Shah Ebrahim |
| author_facet | Tazeen H Jafar Imtiaz Jehan Feng Liang Sylvaine Barbier Muhammad Islam Rasool Bux Aamir Hameed Khan Nivedita Nadkarni Neil Poulter Nish Chaturvedi Shah Ebrahim |
| author_sort | Tazeen H Jafar |
| collection | DOAJ |
| description | Evidence on long term effectiveness of public health strategies for lowering blood pressure (BP) is scarce. In the Control of Blood Pressure and Risk Attenuation (COBRA) Trial, a 2 x 2 factorial, cluster randomized controlled trial, the combined home health education (HHE) and trained general practitioner (GP) intervention delivered over 2 years was more effective than no intervention (usual care) in lowering systolic BP among adults with hypertension in urban Pakistan. However, it was not clear whether the effect would be sustained after the cessation of intervention. We conducted 7 years follow-up inclusive of 5 years of post intervention period of COBRA trial participants to assess the effectiveness of the interventions on BP during extended follow-up.A total of 1341 individuals 40 years or older with hypertension (systolic BP 140 mm Hg or greater, diastolic BP 90 mm Hg or greater, or already receiving treatment) were followed by trained research staff masked to randomization status. BP was measured thrice with a calibrated automated device (Omron HEM-737 IntelliSense) in the sitting position after 5 minutes of rest. BP measurements were repeated after two weeks. Generalized estimating equations (GEE) were used to analyze the primary outcome of change in systolic BP from baseline to 7- year follow-up. The multivariable model was adjusted for clustering, age at baseline, sex, baseline systolic and diastolic BP, and presence of diabetes.After 7 years of follow-up, systolic BP levels among those randomised to combined HHE plus trained GP intervention were significantly lower (2.1 [4.1-0.1] mm Hg) compared to those randomised to usual care, (P = 0.04). Participants receiving the combined intervention compared to usual care had a greater reduction in LDL-cholesterol (2.7 [4.8 to 0.6] mg/dl.The benefit in systolic BP reduction observed in the original cohort assigned to the combined intervention was attenuated but still evident at 7- year follow-up. These findings highlight the potential for scaling-up simple strategies for cardiovascular risk reduction in low- and middle- income countries.ClinicalTrials.gov NCT00327574. |
| first_indexed | 2024-04-14T07:50:04Z |
| format | Article |
| id | doaj.art-2aafb9b5600941459314ae89a26cc688 |
| institution | Directory Open Access Journal |
| issn | 1932-6203 |
| language | English |
| last_indexed | 2024-04-14T07:50:04Z |
| publishDate | 2015-01-01 |
| publisher | Public Library of Science (PLoS) |
| record_format | Article |
| series | PLoS ONE |
| spelling | doaj.art-2aafb9b5600941459314ae89a26cc6882022-12-22T02:05:13ZengPublic Library of Science (PLoS)PLoS ONE1932-62032015-01-011011e014055010.1371/journal.pone.0140550Control of Blood Pressure and Risk Attenuation: Post Trial Follow-Up of Randomized Groups.Tazeen H JafarImtiaz JehanFeng LiangSylvaine BarbierMuhammad IslamRasool BuxAamir Hameed KhanNivedita NadkarniNeil PoulterNish ChaturvediShah EbrahimEvidence on long term effectiveness of public health strategies for lowering blood pressure (BP) is scarce. In the Control of Blood Pressure and Risk Attenuation (COBRA) Trial, a 2 x 2 factorial, cluster randomized controlled trial, the combined home health education (HHE) and trained general practitioner (GP) intervention delivered over 2 years was more effective than no intervention (usual care) in lowering systolic BP among adults with hypertension in urban Pakistan. However, it was not clear whether the effect would be sustained after the cessation of intervention. We conducted 7 years follow-up inclusive of 5 years of post intervention period of COBRA trial participants to assess the effectiveness of the interventions on BP during extended follow-up.A total of 1341 individuals 40 years or older with hypertension (systolic BP 140 mm Hg or greater, diastolic BP 90 mm Hg or greater, or already receiving treatment) were followed by trained research staff masked to randomization status. BP was measured thrice with a calibrated automated device (Omron HEM-737 IntelliSense) in the sitting position after 5 minutes of rest. BP measurements were repeated after two weeks. Generalized estimating equations (GEE) were used to analyze the primary outcome of change in systolic BP from baseline to 7- year follow-up. The multivariable model was adjusted for clustering, age at baseline, sex, baseline systolic and diastolic BP, and presence of diabetes.After 7 years of follow-up, systolic BP levels among those randomised to combined HHE plus trained GP intervention were significantly lower (2.1 [4.1-0.1] mm Hg) compared to those randomised to usual care, (P = 0.04). Participants receiving the combined intervention compared to usual care had a greater reduction in LDL-cholesterol (2.7 [4.8 to 0.6] mg/dl.The benefit in systolic BP reduction observed in the original cohort assigned to the combined intervention was attenuated but still evident at 7- year follow-up. These findings highlight the potential for scaling-up simple strategies for cardiovascular risk reduction in low- and middle- income countries.ClinicalTrials.gov NCT00327574.http://europepmc.org/articles/PMC4634976?pdf=render |
| spellingShingle | Tazeen H Jafar Imtiaz Jehan Feng Liang Sylvaine Barbier Muhammad Islam Rasool Bux Aamir Hameed Khan Nivedita Nadkarni Neil Poulter Nish Chaturvedi Shah Ebrahim Control of Blood Pressure and Risk Attenuation: Post Trial Follow-Up of Randomized Groups. PLoS ONE |
| title | Control of Blood Pressure and Risk Attenuation: Post Trial Follow-Up of Randomized Groups. |
| title_full | Control of Blood Pressure and Risk Attenuation: Post Trial Follow-Up of Randomized Groups. |
| title_fullStr | Control of Blood Pressure and Risk Attenuation: Post Trial Follow-Up of Randomized Groups. |
| title_full_unstemmed | Control of Blood Pressure and Risk Attenuation: Post Trial Follow-Up of Randomized Groups. |
| title_short | Control of Blood Pressure and Risk Attenuation: Post Trial Follow-Up of Randomized Groups. |
| title_sort | control of blood pressure and risk attenuation post trial follow up of randomized groups |
| url | http://europepmc.org/articles/PMC4634976?pdf=render |
| work_keys_str_mv | AT tazeenhjafar controlofbloodpressureandriskattenuationposttrialfollowupofrandomizedgroups AT imtiazjehan controlofbloodpressureandriskattenuationposttrialfollowupofrandomizedgroups AT fengliang controlofbloodpressureandriskattenuationposttrialfollowupofrandomizedgroups AT sylvainebarbier controlofbloodpressureandriskattenuationposttrialfollowupofrandomizedgroups AT muhammadislam controlofbloodpressureandriskattenuationposttrialfollowupofrandomizedgroups AT rasoolbux controlofbloodpressureandriskattenuationposttrialfollowupofrandomizedgroups AT aamirhameedkhan controlofbloodpressureandriskattenuationposttrialfollowupofrandomizedgroups AT niveditanadkarni controlofbloodpressureandriskattenuationposttrialfollowupofrandomizedgroups AT neilpoulter controlofbloodpressureandriskattenuationposttrialfollowupofrandomizedgroups AT nishchaturvedi controlofbloodpressureandriskattenuationposttrialfollowupofrandomizedgroups AT shahebrahim controlofbloodpressureandriskattenuationposttrialfollowupofrandomizedgroups |